UCB Korea, Samil to strengthen co-marketing over Xyzal

Published: 2009-04-30 06:58:00
Updated: 2009-04-30 06:58:00
UCB Korea and Samil Pharm will beef up their co-marketing efforts of XYZAL (levocetirizine), a third-generation non-sedative antihistamine.

Many people suffer from the symptoms associated with common allergic conditions. The immune system of allergy sufferers over-reacts to something in the en...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.